These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8070603)

  • 1. Uterine leiomyomata and endometrial proliferation in postmenopausal women treated with the anti-oestrogen tamoxifen.
    Ugwumadu AH; Harding K
    Eur J Obstet Gynecol Reprod Biol; 1994 Apr; 54(2):153-6. PubMed ID: 8070603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitotically active leiomyoma of the uterus in a postmenopausal breast cancer patient receiving tamoxifen.
    Liu IF; Yen YS; Cheng YM; Chou CY
    Taiwan J Obstet Gynecol; 2006 Jun; 45(2):167-9. PubMed ID: 17197361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial polyps, cystic glandular hyperplasia and atypical leiomyoma associated with tamoxifen therapy.
    Kimya Y; Cengiz C; Tolunay S
    Int J Gynaecol Obstet; 1994 Jul; 46(1):69-70. PubMed ID: 7805990
    [No Abstract]   [Full Text] [Related]  

  • 4. Surveillance of endometrial pathologies, especially for endometrial cancer, of breast cancer patients under tamoxifen treatment.
    Neri F; Maggino T
    Eur J Gynaecol Oncol; 2009; 30(4):357-60. PubMed ID: 19761121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different coexisting endometrial histological features in asymptomatic postmenopausal breast cancer patients treated with tamoxifen.
    Cohen I; Altaras MM; Shapira J; Tepper R; Cordoba M; Figer A; Zalel Y; Dror Y; Beyth Y
    Gynecol Obstet Invest; 1997; 43(1):60-3. PubMed ID: 9015703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer.
    Ebert AD; Rosenow G; David M; Mechsner S; Magalov IS; Papadopoulos T
    Gynecol Obstet Invest; 2008; 66(3):209-13. PubMed ID: 18645252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
    Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
    J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen and the uterus and endometrium.
    Neven P; De Muylder X; Van Belle Y; Vanderick G; De Muylder E
    Lancet; 1989 Feb; 1(8634):375. PubMed ID: 2563519
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of endometrial proliferation in pipelle biopsies in tamoxifen-treated postmenopausal women with breast cancer in Kuwait.
    Al-Azemi M; Labib NS; Motawy MM; Temmim L; Moussa MA; Omu AE
    Med Princ Pract; 2004; 13(1):30-4. PubMed ID: 14657616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen-induced growth of leiomyomas. A case report.
    Kang J; Baxi L; Heller D
    J Reprod Med; 1996 Feb; 41(2):119-20. PubMed ID: 8656411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal tamoxifen treatment and endometrial pathology.
    Cohen I; Altaras MM; Shapira J; Tepper R; Beyth Y
    Obstet Gynecol Surv; 1994 Dec; 49(12):823-9. PubMed ID: 7885659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gynaecological complications of women treated with tamoxifen for breast cancer.
    Dew JE; Eden JA
    Aust N Z J Obstet Gynaecol; 1995 May; 35(2):198-200. PubMed ID: 7677689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring.
    Vosse M; Renard F; Coibion M; Neven P; Nogaret JM; Hertens D
    Eur J Obstet Gynecol Reprod Biol; 2002 Feb; 101(1):58-63. PubMed ID: 11803101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
    Cohen I; Beyth Y; Altaras MM; Shapira J; Tepper R; Cardoba M; Yigael D; Figer A; Fishman A; Berenhein J
    Gynecol Oncol; 1997 Oct; 67(1):8-15. PubMed ID: 9345349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic effects of tamoxifen on the uterine epithelium of breast cancer patients: analysis by menopausal status.
    McGonigle KF; Lantry SA; Odom-Maryon TL; Chai A; Vasilev SA; Simpson JF
    Cancer Lett; 1996 Mar; 101(1):59-66. PubMed ID: 8625283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sonohysterography compared with endometrial biopsy for evaluation of the endometrium in tamoxifen-treated women.
    Hann LE; Kim CM; Gonen M; Barakat R; Choi PH; Bach AM
    J Ultrasound Med; 2003 Nov; 22(11):1173-9. PubMed ID: 14620887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast cancer, tamoxifen, and uterus].
    Palacios A; Pertusa S; Montoya A; Martínez San Pedro R
    Med Clin (Barc); 1993 Mar; 100(12):479. PubMed ID: 8479228
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose-dependent effect of tamoxifen therapy on endometrial pathologies in postmenopausal breast cancer patients.
    Cohen I; Perel E; Tepper R; Flex D; Figer A; Shapira J; Altaras MM; Fishman A; Bernheim J; Cordoba M; Yigael D; Beyth Y
    Breast Cancer Res Treat; 1999 Feb; 53(3):255-62. PubMed ID: 10369071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expansive uterine myoma during tamoxifen therapy. 11 cases].
    Le Bouëdec G; de Latour M; Dauplat J
    Presse Med; 1995 Nov; 24(36):1694-6. PubMed ID: 8545398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial.
    Kedar RP; Bourne TH; Powles TJ; Collins WP; Ashley SE; Cosgrove DO; Campbell S
    Lancet; 1994 May; 343(8909):1318-21. PubMed ID: 7910323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.